Login / Signup

Efficacy and safety in the treatment of hyperprolactinemia: A systematic review and network meta-analysis.

Mariana Millan FachiLays de Deus BuenoDenise Colaço de OliveiraLetícia Lazarin da SilvaAline F Bonetti
Published in: Journal of clinical pharmacy and therapeutics (2021)
This is the first network meta-analysis that evaluated the efficacy and safety of dopaminergic agonists in the treatment of hyperprolactinemia. The results of this review revealed that these drugs have similar efficacy, but cabergoline has a better safety profile.
Keyphrases
  • systematic review
  • combination therapy
  • network analysis